Latest On-Demand Webinars

In this webinar, our guest speakers will be discussing how to harness the full power of this disease-agnostic RNA platform, the key considerations needed for consistent, high-quality mRNA synthesis and how you can intensify manufacturing for rapid therapeutic production.

Here, Dr. Riglar will discuss ways that we are using synthetic biology to solve this problem, and our quest to develop non-invasive living engineered bacterial tools – smart probiotics – to help us understand and control the gut and gut microbiota.

Co-targeting of two receptors or ligands that are involved in modulating a patient’s immune system via a single molecular format provides advantages over the co-administration of two biologics.

Co-targeting of two receptors or ligands that are involved in modulating a patient’s immune system via a single molecular format provides advantages over the co-administration of two biologics.

In this webinar, our expert speaker Dr. Ceri Fielding, from the division of infection and immunity at Cardiff University, will discuss the need to understand how viruses interact with NK cells during the development of novel antiviral therapies.

Design–build–test–learn (DBTL) cycles are commonly used in biotechnology and in natural product discovery as they provide a systemic and efficient framework for the metabolic engineering of microbes.

A novel platform that automates multiomics analyses of microbes could enable faster and better DBLT cycles for your research. In this webinar, the development and validation of the high-throughput, automated platform using model microbial organisms is described, as well as the recent work in applying the platform to cell factory and natural products engineering.

This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.

This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe the development and use of a new assay to investigate important proteins in disease screening and the biopharmaceutical industry.

Map proteins, examine metabolic activity and dig deeper into cellular biology by adding spatial localization to your current methodologies. In this webinar, we’ll showcase this novel workflow, highlighting the benefits it can bring to your research.

In this webinar, Dr. Catherine Houlihan, will describe an unrecognized case of viral hemorrhagic fever imported into the UK and the important lessons learned for the emergency clinicians, GPs, virologists, infection specialists and public health doctors.